Companies: 10,795·Total market cap: $144.5T
BNB Plus Corp.

BNB Plus Corp.

BNBXNASDAQHealthcare● Active
$0.54
$-0.00(-0.18%)
Market Cap$697335
P/E Ratio—
52W High$7.15
52W Low$0.35
PE RatioMarket CapForecast

BNB Plus Corp. (BNBX) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

bnbx · pe ratio · data through Sep 30, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for BNB Plus Corp. (BNBX) measures how much investors pay for each dollar of the company's trailing earnings. BNBX's current PE ratio of N/A is calculated by dividing its stock price of $0.54 by its TTM earnings per share of -$3.54.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-09-30

Forward P/E
N/A
FY2026 est. EPS $-82.50
Based on 1 analyst
EPS (TTM)
-$3.54
TTM · diluted EPS
PEG Ratio
0.00
Below 1.0 · Growth adjusted
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · BNB Plus Corp. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2021 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
BNB Plus Corp.
BNB Plus Corp.You
BNBX
$1MN/A—-$3.54
Bio Green Med Solution, Inc.
Bio Green Med Solution, Inc.
BGMS
$2MN/A—-$1.37
Bionano Genomics, Inc.
Bionano Genomics, Inc.
BNGO
$4MN/A—-$4.85
Can-Fite BioPharma Ltd.
Can-Fite BioPharma Ltd.
CANF
$2MN/A—-$12.02
iSpecimen Inc.
iSpecimen Inc.
ISPC
$0MN/A—-$91.15
Kazia Therapeutics Limited
Kazia Therapeutics Limited
KZIA
$18MN/A—-$18.90
NanoVibronix, Inc.
NanoVibronix, Inc.
NAOV
$2MN/A—-$28.93

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 5 of 5 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-09-30Latest
FY2025
—$-29.29—
2024-09-30
FY2024
—$-66.12—
2023-09-30
FY2023
—$-570.59—
2022-09-30
FY2022
—$-9613.83—
2021-09-30
FY2021
—$-28630.14—

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for BNB Plus Corp. (BNBX) measures how much investors pay for each dollar of the company's trailing earnings. BNBX's current PE ratio of N/A is calculated by dividing its stock price of $0.54 by its TTM earnings per share of -$3.54.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.54 ÷ -$3.54 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.
Price historyFinancial statementsEarnings

Frequently asked questions

BNBX pe ratio · 6 questions

BNBX's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.54 and TTM EPS of -$3.54. Data sourced from Financial Modeling Prep via BNBX's SEC 10-K and 10-Q filings.

BNBX PE ratioWhat is BNBX PE ratioCurrent PE ratio of BNBXBNBX PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · BNB Plus Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08